Ads
related to: eosinophilic asthma treatment nucala icd 10- Indications For NUCALA
Learn More About Various Approved
Indications For NUCALA & View PI.
- Dosing & Administration
Get Dosing & Administration
Information For NUCALA.
- How Does NUCALA Work?
Discover Facts Related To The MOA
Of NUCALA To Learn How It Works.
- Learn About NUCALA
Get Info About NUCALA To Share With
Your Patients & Request A Rep Today
- Clinical Trial Data
View Clinical Data & Information
About NUCALA To Learn More.
- NUCALA Patient Profiles
Physicians: Identify If NUCALA
Is Right For Your Patients.
- Indications For NUCALA
Search results
Results From The WOW.Com Content Network
Mepolizumab. Mepolizumab, sold under the brand name Nucala by GlaxoSmithKline, is a humanized monoclonal antibody used for the treatment of severe eosinophilic asthma, eosinophilic granulomatosis with polyangiitis, and hypereosinophilic syndrome (HES). [ 5 ] It recognizes and blocks interleukin-5 (IL-5), a signalling protein of the immune system.
Nucala, known also as mepolizumab, was first approved in 2015 for a type of severe asthma in the United States. Its sales grew 18% to 1.7 billion pounds in 2023. It contributed nearly 6% to GSK ...
Anti-asthmatic agents. Anti-asthmatic agents refer to drugs that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies and related ...
Dexpramipexole is a first-in-class oral investigational medicine that lowers blood and tissue eosinophils before they can cause damage in the target organ. Dexpramipexole is being developed by Areteia Therapeutics and has the potential to be the first oral treatment ever approved for eosinophilic asthma.
Depending on eosinophil target-organ infiltration, the clinical presentation of hypereosinophilic syndrome (HES) varies from patient to patient. [13] Individuals with myeloproliferative variant HES may be more likely to experience mucosal ulcerations involving the genitalia or airways, while patients with lymphocytic variant HES typically exhibit prominent skin symptoms such as urticarial ...
144 590.40 g·mol −1. Tezepelumab, sold under the brand name Tezspire, is a human monoclonal antibody used for the treatment of asthma. [5][7][8][9] Tezepelumab blocks thymic stromal lymphopoietin (TSLP), [5] an epithelial cytokine that has been suggested to be critical in the initiation and persistence of airway inflammation. [10]
Ads
related to: eosinophilic asthma treatment nucala icd 10